LIVE

Serial Number

97340231

Owner

RB Health (US) LLC

Attorney

Mark Lerner, Esq.

First Use Date

Dec 31, 2021

Filing Date

Mar 31, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

MUCUS Trademark

Serial Number: 97340231 • Registration: 8215005

MUCUS is a trademark filed by RB Health (US) LLC on March 31, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

RB Health (US) LLC (3 trademarks)

399 Interpace Parkway
Parsippany, NJ 07054

Entity Type: 16

Legal Representation

Attorney of Record

Mark Lerner, Esq.

1,474 trademarks filed View all →

Correspondence Address

Mark Lerner, Esq. DUANE MORRIS LLP

335 Madison Avenue - 23rd Floor

22 Vanderbilt

NEW YORK, NY 10017

United States

Trademark Details

Filing Date

March 31, 2022

Registration Date

April 14, 2026

First Use Anywhere

December 31, 2021

First Use in Commerce

December 31, 2021

Published for Opposition

July 11, 2023

Goods & Services

Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparations, namely, pharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds; allergy relief medication; antihistamines

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 14, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Apr 14, 2026 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 23, 2026 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 23, 2026 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Mar 3, 2026 SUPC

USE AMENDMENT FILED

Mar 2, 2026 IUAF

TEAS STATEMENT OF USE RECEIVED

Mar 2, 2026 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 10, 2025 EXRA

SOU EXTENSION 4 GRANTED

Sep 10, 2025 EX4G

SOU TEAS EXTENSION RECEIVED

Sep 2, 2025 EEXT

SOU EXTENSION 4 FILED

Sep 1, 2025 EXT4

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 20, 2025 EXRA

SOU EXTENSION 3 GRANTED

Feb 19, 2025 EX3G

SOU EXTENSION 3 FILED

Feb 18, 2025 EXT3

SOU TEAS EXTENSION RECEIVED

Feb 18, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 16, 2024 EXRA

SOU EXTENSION 2 GRANTED

Nov 16, 2024 EX2G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 16, 2024 AITU

SOU EXTENSION 2 FILED

Aug 28, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Aug 28, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 28, 2024 EXRA

SOU EXTENSION 1 GRANTED

Feb 27, 2024 EX1G

SOU EXTENSION 1 FILED

Feb 27, 2024 EXT1

SOU TEAS EXTENSION RECEIVED

Feb 27, 2024 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 5, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 11, 2023 NPUB

PUBLISHED FOR OPPOSITION

Jul 11, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 21, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 7, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

May 19, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 19, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 19, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 28, 2022 GNRN

NON-FINAL ACTION E-MAILED

Nov 28, 2022 GNRT

NON-FINAL ACTION WRITTEN

Nov 28, 2022 CNRT

ASSIGNED TO EXAMINER

Nov 21, 2022 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Apr 6, 2022 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 5, 2022 NWOS

NEW APPLICATION ENTERED

Apr 4, 2022 NWAP

Related Trademarks

More from this Owner

THE DUO THAT DOES MORE

NEURIVA

MUCINEX DM

RECHARGE NIGHTTIME COLD & FLU

More in Same Class

NGMBIO

NGM BIOPHARMACEUTICALS